Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Cash from Financing Activities (2023 - 2025)

Upstream Bio has reported Cash from Financing Activities over the past 3 years, most recently at $1.1 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at $1.1 million for Q4 2025, down 99.59% from a year ago — trailing twelve months through Dec 2025 was $2.4 million (down 99.42% YoY), and the annual figure for FY2025 was $2.4 million, down 99.42%.
  • Cash from Financing Activities for Q4 2025 was $1.1 million at Upstream Bio, up from $760000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for UPB hit a ceiling of $270.6 million in Q4 2024 and a floor of -$1.6 million in Q3 2024.
  • Median Cash from Financing Activities over the past 3 years was $760000.0 (2025), compared with a mean of $46.8 million.
  • Biggest five-year swings in Cash from Financing Activities: surged 203594.74% in 2024 and later tumbled 100.36% in 2025.
  • Upstream Bio's Cash from Financing Activities stood at -$133000.0 in 2023, then surged by 203594.74% to $270.6 million in 2024, then crashed by 99.59% to $1.1 million in 2025.
  • The last three reported values for Cash from Financing Activities were $1.1 million (Q4 2025), $760000.0 (Q3 2025), and $612000.0 (Q2 2025) per Business Quant data.